000 03735nam a22004695i 4500
001 978-3-540-40901-4
003 DE-He213
005 20161121230741.0
007 cr nn 008mamaa
008 100301s2007 gw | s |||| 0|eng d
020 _a9783540409014
_9978-3-540-40901-4
024 7 _a10.1007/978-3-540-40901-4
_2doi
050 4 _aRC254-282
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a616.994
_223
245 1 0 _aProstate Cancer
_h[electronic resource] /
_cedited by Jacob Ramon, Louis J. Denis.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg,
_c2007.
300 _aXIII, 271 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aRecent Results in Cancer Research,
_x0080-0015 ;
_v175
505 0 _aEpidemiology of Prostate Cancer -- Natural History of Prostatic Carcinoma: The Pathologist’s Perspective -- Prognostic Factors in Prostate Cancer -- The Prevention of Prostate Cancer -- Prostate Cancer Screening -- Diagnosis of Prostate Cancer -- Does Localized Prostate Cancer Exist? -- Staging of Prostate Cancer -- Guidelines and Counselling for Treatment Options in the Management of Prostate Cancer -- Choices for Surgery -- Radiation Therapy in Prostate Cancer -- Cryoablation and High-Intensity Focused Ultrasound -- The Role of Hormonal Treatment in Prostate Cancer -- Androgen-Independent Prostate Cancer -- Prostate Cancer Treatment and Quality of Life -- Europa Uomo: The European Prostate Cancer Coalition.
520 _aProstate cancer treatment dates back almost treatment approaches is examined in the subse- 100years. However, in an era of rapid develop- quent chapters of this volume. ments and innovations in cancer research and Te text addresses the time-honoured h- uro-oncology, there is an increasing need to monal treatment, which has been the mainstay update our knowledge and especially to guide of prostate cancer management for some - our practice by innovations and evidence-based cades. Due to the increased diagnosis of prostate medicine. Prostate cancer is still evolving fol- cancer at earlier stages and the increased use of lowing improvements in disease detection and hormone therapy in earlier disease stages many better understanding of disease characteristics. patients will receive hormone therapy for a long Tis book addresses the current state of the art in period. Tese patients are at risk of acute and this still-developing feld and presents the reader chronic side efects of hormonal therapy. Te- with the information needed to make rational fore, the timing of initiating hormone therapy, patient decisions regarding treatment selection the type of hormone therapy and the monitoring and outcomes. of patients on long-term hormone therapy have Te growing body of knowledge regarding become crucial in the appropriate management epidemiology, pathogenesis, prevention, screen- of patients with prostate cancer. ing, diagnosis and staging is included in the frst Disease management in men with prostate half of the book.
650 0 _aMedicine.
650 0 _aOncology.
650 0 _aUrology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aOncology.
650 2 4 _aUrology.
700 1 _aRamon, Jacob.
_eeditor.
700 1 _aDenis, Louis J.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783540408970
830 0 _aRecent Results in Cancer Research,
_x0080-0015 ;
_v175
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-540-40901-4
912 _aZDB-2-SME
950 _aMedicine (Springer-11650)
999 _c503428
_d503428